DIN 02359456 — DAXAS 500 MCG
DAXAS is a tablet of Roflumilast marketed by ASTRAZENECA CANADA INC. The full Roflumilast monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02359456
- Brand name
- DAXAS
- Active ingredient
- Roflumilast
- Strength
- 500 MCG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- ASTRAZENECA CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Phosphodiesterase-4 (PDE4) inhibitor
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.